TY  - JOUR
AU  - Martín-Escolano, Rubén
AU  - Cebrián, Rubén
AU  - Martín-Escolano, Javier
AU  - Rosales, Maria J
AU  - Maqueda, Mercedes
AU  - Sánchez-Moreno, Manuel
AU  - Marín, Clotilde
PY  - 2019
DO  - 10.1016/j.ijpddr.2019.03.003
UR  - http://hdl.handle.net/10668/13794
T2  - International journal for parasitology. Drugs and drug resistance
AB  - Chagas disease caused by the protozoan parasite Trypanosoma cruzi represents a significant public health problem in Latin America, affecting around 8 million cases worldwide. Nowadays is urgent the identification of new antichagasic agents as the only...
LA  - en
KW  - AS-48
KW  - Antichagasic agent
KW  - Bacteriocin
KW  - Drug discovery
KW  - Trypanosoma cruzi
KW  - Animals
KW  - Bacteriocins
KW  - Chagas Disease
KW  - Enterococcus faecalis
KW  - Mitochondria
KW  - Nitroimidazoles
KW  - Reactive Oxygen Species
KW  - Trypanocidal Agents
KW  - Trypanosoma cruzi
TI  - Insights into Chagas treatment based on the potential of bacteriocin AS-48.
TY  - research article
VL  - 10
ER  -